These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38217066)

  • 21. "Endemic paraplegia of Koza in Kii" in Honcho Koji Innen Shu published in 1689 is probably the earliest description of amyotrophic lateral sclerosis of Kii Peninsula: Presentation of the original and investigation of factuality.
    Kuzuhara S
    Rinsho Shinkeigaku; 2021 Dec; 61(12):815-824. PubMed ID: 34744090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
    Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
    J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotyping of presenilin-1 polymorphism in amyotrophic lateral sclerosis.
    Panas M; Karadima G; Kalfakis N; Psarrou O; Floroskoufi P; Kladi A; Petersen MB; Vassilopoulos D
    J Neurol; 2000 Dec; 247(12):940-2. PubMed ID: 11200686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis.
    Ferraiuolo L; Kirby J; Grierson AJ; Sendtner M; Shaw PJ
    Nat Rev Neurol; 2011 Nov; 7(11):616-30. PubMed ID: 22051914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult onset Sandhoff disease: a rare mimicker of amyotrophic lateral sclerosis.
    Khoueiry M; Malek E; Salameh JS
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):144-146. PubMed ID: 31512525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene.
    Giess R; Holtmann B; Braga M; Grimm T; Müller-Myhsok B; Toyka KV; Sendtner M
    Am J Hum Genet; 2002 May; 70(5):1277-86. PubMed ID: 11951178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72.
    Boeve BF; Boylan KB; Graff-Radford NR; DeJesus-Hernandez M; Knopman DS; Pedraza O; Vemuri P; Jones D; Lowe V; Murray ME; Dickson DW; Josephs KA; Rush BK; Machulda MM; Fields JA; Ferman TJ; Baker M; Rutherford NJ; Adamson J; Wszolek ZK; Adeli A; Savica R; Boot B; Kuntz KM; Gavrilova R; Reeves A; Whitwell J; Kantarci K; Jack CR; Parisi JE; Lucas JA; Petersen RC; Rademakers R
    Brain; 2012 Mar; 135(Pt 3):765-83. PubMed ID: 22366793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis).
    Jawdat O; Statland JM; Barohn RJ; Katz JS; Dimachkie MM
    Neurol Clin; 2015 Nov; 33(4):775-85. PubMed ID: 26515621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1
    Shang HY; Zhang JJ; Fu ZF; Liu YF; Li S; Chen S; Le WD
    CNS Neurosci Ther; 2020 Jan; 26(1):90-100. PubMed ID: 31318169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purinergic P2X
    Mckenzie ADJ; Garrett TR; Werry EL; Kassiou M
    ACS Chem Neurosci; 2022 May; 13(10):1479-1490. PubMed ID: 35512313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis.
    Rué L; Oeckl P; Timmers M; Lenaerts A; van der Vos J; Smolders S; Poppe L; de Boer A; Van Den Bosch L; Van Damme P; Weishaupt JH; Ludolph AC; Otto M; Robberecht W; Lemmens R
    Acta Neuropathol Commun; 2019 Jul; 7(1):114. PubMed ID: 31300041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supportive care needs of patients with amyotrophic lateral sclerosis/motor neuron disease and their caregivers: A scoping review.
    Oh J; Kim JA
    J Clin Nurs; 2017 Dec; 26(23-24):4129-4152. PubMed ID: 28681543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Motor neuron-derived microRNAs cause astrocyte dysfunction in amyotrophic lateral sclerosis.
    Hoye ML; Regan MR; Jensen LA; Lake AM; Reddy LV; Vidensky S; Richard JP; Maragakis NJ; Rothstein JD; Dougherty JD; Miller TM
    Brain; 2018 Sep; 141(9):2561-2575. PubMed ID: 30007309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.
    Vercruysse P; Sinniger J; El Oussini H; Scekic-Zahirovic J; Dieterlé S; Dengler R; Meyer T; Zierz S; Kassubek J; Fischer W; Dreyhaupt J; Grehl T; Hermann A; Grosskreutz J; Witting A; Van Den Bosch L; Spreux-Varoquaux O; ; Ludolph AC; Dupuis L
    Brain; 2016 Apr; 139(Pt 4):1106-22. PubMed ID: 26984187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation.
    D'Ambrosi N; Cozzolino M; Carrì MT
    Antioxid Redox Signal; 2018 Jul; 29(1):15-36. PubMed ID: 28895473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative assessment of blood Metal/metalloid levels, clinical heterogeneity, and disease severity in amyotrophic lateral sclerosis patients.
    Qin X; Wu P; Wen T; Jia R; Zhang R; Jin J; Hu F; Chen QY; Dang J
    Neurotoxicology; 2022 Mar; 89():12-19. PubMed ID: 35007622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deterministic-tractography-based approach for diagnosis and disease monitoring of amyotrophic lateral sclerosis.
    Sako W; Abe T; Izumi Y; Harada M; Kaji R
    Clin Neurol Neurosurg; 2019 Jun; 181():73-75. PubMed ID: 31009854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
    Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
    Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia.
    Shahrizaila N; Sobue G; Kuwabara S; Kim SH; Birks C; Fan DS; Bae JS; Hu CJ; Gourie-Devi M; Noto Y; Shibuya K; Goh KJ; Kaji R; Tsai CP; Cui L; Talman P; Henderson RD; Vucic S; Kiernan MC
    J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):821-30. PubMed ID: 27093948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.